What is the management for an infection related to a nasogastric tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Nasogastric Tube-Related Infections

Nasogastric tube-related infections should be promptly treated with site-specific care, appropriate antimicrobial therapy, and removal of the tube when clinically feasible to reduce morbidity and mortality.

Diagnosis and Assessment

When evaluating a patient with a suspected nasogastric tube-related infection, look for:

  • Signs of local infection:

    • Erythema around insertion site
    • Purulent or malodorous exudate
    • Pain at the site
    • Loss of skin integrity 1
  • Systemic signs:

    • Fever
    • Elevated inflammatory markers
    • Signs of sepsis in severe cases
  • Obtain appropriate cultures:

    • Swab the site for bacterial culture if purulent drainage or significant erythema is present
    • Consider fungal culture if white plaques or satellite lesions are present 1

Treatment Algorithm

1. Local Infection (Insertion Site)

  • Clean the site daily with antimicrobial cleanser 1
  • Apply appropriate topical therapy based on suspected pathogen:
    • For bacterial infection: Topical antimicrobial agents or antimicrobial dressings (silver, iodine, or polyhexamethylene biguanide) 1
    • For fungal infection: Nystatin cream until signs resolve 1
  • Apply barrier film or cream to protect surrounding skin if exudate is present 1

2. Systemic Infection

  • For mild-moderate infections:

    • Amoxicillin/clavulanate OR
    • Ceftriaxone + Metronidazole OR
    • Cefotaxime + Metronidazole 1
  • For severe or healthcare-associated infections:

    • Piperacillin/Tazobactam OR
    • Cefepime + Metronidazole 1
  • For β-lactam allergy:

    • Ciprofloxacin + Metronidazole OR
    • Moxifloxacin 1

3. Tube Management

  • Remove the nasogastric tube as soon as clinically indicated to reduce infection risk 2
  • If continued enteral access is needed, consider:
    • Replacing the infected tube with a new one
    • Converting to a different type of enteral access (e.g., PEG tube) for long-term use

Special Considerations

Prevention of Complications

  • Elevate the head of the bed 30-45° for patients with nasogastric tubes to reduce aspiration risk 2
  • Routinely verify appropriate tube placement to prevent complications 2
  • Assess intestinal motility (bowel sounds, residual gastric volume) and adjust feeding rate/volume to prevent regurgitation 2
  • Avoid unnecessary use of nasogastric tubes, as they are associated with:
    • Increased risk of aspiration pneumonia 3
    • Poorer outcomes in Clostridium difficile infection (81% increased risk) 4
    • Colonization with gram-negative bacteria 3

Medication Administration Through Infected Tubes

  • For patients requiring continued medication through infected tubes:
    • Ensure proper crushing of medications when appropriate 5
    • Flush tube with 30-40ml water before and after medication administration 1
    • Consider alternative routes if infection is severe

High-Risk Patients

Pay special attention to patients with:

  • Diabetes
  • Obesity
  • Poor nutritional status
  • Immunosuppressive therapy
  • Chronic corticosteroid use
  • Hyper-hydrated or inflamed skin 1

Common Pitfalls to Avoid

  • Delaying tube removal when no longer needed
  • Using prophylactic systemic antibiotics for routine care
  • Overtightening external fixation devices
  • Neglecting fungal infections
  • Using topical antibiotics inappropriately 1

By following this structured approach to managing nasogastric tube-related infections, you can effectively treat the infection while minimizing complications and improving patient outcomes.

References

Guideline

Management of PEG Tube Site Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia.

Current opinion in clinical nutrition and metabolic care, 2003

Research

Successful treatment of severe Clostridium difficile infection by administration of crushed fidaxomicin via a nasogastric tube in a critically ill patient.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.